| Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner ZP Gill, CM Perks, PV Newcomb, JMP Holly Journal of Biological Chemistry 272 (41), 25602-25607, 1997 | 275 | 1997 |
| The role of insulin-like growth factor binding proteins J Holly, C Perks Neuroendocrinology 83 (3-4), 154-160, 2006 | 184 | 2006 |
| Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding … KW Colston, CM Perks, SP Xie, JM Holly Journal of Molecular Endocrinology 20 (1), 157-162, 1998 | 177 | 1998 |
| Caffeine and caffeic acid inhibit growth and modify estrogen receptor and insulin-like growth factor I receptor levels in human breast cancer AH Rosendahl, CM Perks, L Zeng, A Markkula, M Simonsson, C Rose, ... Clinical Cancer Research 21 (8), 1877-1887, 2015 | 175 | 2015 |
| Differential IGF‐independent effects of insulin‐like growth factor binding proteins (1–6) on apoptosis of breast epithelial cells CM Perks, S Bowen, ZP Gill, PV Newcomb, JMP Holly Journal of cellular biochemistry 75 (4), 652-664, 1999 | 145 | 1999 |
| IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells CM Perks, EG Vernon, AH Rosendahl, D Tonge, JMP Holly Oncogene 26 (40), 5966-5972, 2007 | 143 | 2007 |
| Prolactin acts as a potent survival factor for human breast cancer cell lines CM Perks, AJ Keith, KL Goodhew, PB Savage, ZE Winters, JMP Holly British journal of cancer 91 (2), 305-311, 2004 | 137 | 2004 |
| Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells AC Williams, TJ Collard, CM Perks, P Newcomb, M Moorghen, JMP Holly, ... Cancer Research 60 (1), 22-27, 2000 | 132 | 2000 |
| Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells CM Perks, PV Newcomb, MR Norman, JMP Holly Journal of molecular endocrinology 22 (2), 141-150, 1999 | 132 | 1999 |
| Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of … C McCaig, CM Perks, JMP Holly Journal of cell science 115 (22), 4293-4303, 2002 | 124 | 2002 |
| Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase L Zeng, KM Biernacka, JMP Holly, C Jarrett, AA Morrison, A Morgan, ... Endocrine-related cancer 17 (2), 539-551, 2010 | 121 | 2010 |
| Localization of messenger ribonucleic acids for insulin-like growth factor I (IGF-I), IGF-II, and the type 1 IGF receptor in the ovine ovary throughout the estrous cycle CM Perks, PA Denning-Kendall, RS Gilmour, DC Wathes Endocrinology 136 (12), 5266-5273, 1995 | 117 | 1995 |
| Follicular and luteal expression of insulin-like growth factors I and II and the type 1 IGF receptor in the bovine ovary CM Perks, AR Peters, DC Wathes Reproduction 116 (1), 157-165, 1999 | 114 | 1999 |
| Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis S Harrison, R Lennon, J Holly, JPT Higgins, M Gardner, C Perks, T Gaunt, ... Cancer Causes & Control 28, 497-528, 2017 | 109 | 2017 |
| Insulin-like growth factor physiology: what we have learned from human studies JMP Holly, CM Perks Endocrinology and Metabolism Clinics 41 (2), 249-263, 2012 | 99 | 2012 |
| IGFBP‐3 prolongs the p53 response and enhances apoptosis following UV irradiation AD Hollowood, T Lai, CM Perks, PV Newcomb, D Alderson, JMP Holly International journal of cancer 88 (3), 336-341, 2000 | 94 | 2000 |
| Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2 KM Biernacka, CC Uzoh, L Zeng, RA Persad, A Bahl, D Gillatt, CM Perks, ... Endocr Relat Cancer 20 (5), 741-51, 2013 | 93 | 2013 |
| Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or-independent mechanisms and reduces the efficacy of docetaxel CC Uzoh, JMP Holly, KM Biernacka, RA Persad, A Bahl, D Gillatt, ... British journal of cancer 104 (10), 1587-1593, 2011 | 90 | 2011 |
| Insulin-like growth factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor EJ Foulstone, L Zeng, CM Perks, JMP Holly Endocrinology 154 (5), 1780-1793, 2013 | 81 | 2013 |
| Blood lipids and prostate cancer: a Mendelian randomization analysis CJ Bull, C Bonilla, JMP Holly, CM Perks, N Davies, P Haycock, OHY Yu, ... Cancer medicine 5 (6), 1125-1136, 2016 | 79 | 2016 |
